ALiA Large.png

Small, multiplex, traceable.

The ALiA® SARS-CoV-2 Antigen FIA Test employs a unique immunofluorescent-based BioChip with our advanced microfluidic and microarray technologies for the qualitative detection of nucleocapsid protein from SARS-CoV-2. The ALiA® SARS-CoV-2 Antigen FIA Test delivers a 20-minute result of direct nasopharyngeal swab from COVID-19 suspected patient with symptoms onset within 14 days.


A microscopic test site used to capture molecules and perform multiplex immunoassays.

Patented Technologies

All our innovative Intellectual properties are protected.



We use the high accuracy of florescent immunoassay to produce test results.

Safe & Easy to Use

Weighing only 5 kgs and equipped with an easy-to-use GUI, ALiA is operable by any personnell with minimal training.

Game-Changing Features

ALiA is equipped with an array of high-tech, user-friendly designs to provide medical professionals with a quick and reliable diagnosis solution.


A full-size lab shrunken to the size of a credit card.


Traceable BioChips allow us to track product cycles and identify counterfeits.

Virus Studies
React ∘ Respond ∘ Reconnect

Our Diagnosis Panels

With the flexibility of microarray technology, we have developed a single test for COVID-19, duplex for FluA and FluB, quadruplex (4-in-1) for FluA, FluB, RSV, HAdV, and 5-in-1 for FluA, FluB, RSV, HAdV, COVID-19, to offer the most appropriate support to medical professionals at the frontline. 



It's that easy.


1. Load sample into BioChip


2. Insert into the tray and enter ID


3. Read the results and print

Customer Support Agent
Want to know more?

Contact us now to learn more about our product and pricing plans.